Treatment of alcohol use disorder in patients with alcohol-associated liver disease: Innovative approaches and a call to action

被引：0
作者：
Lamia Y. Haque
Paola Zuluaga
Robert Muga
Daniel Fuster
机构：
[1] Digestive Diseases,Department of Medicine
[2] & Program in Addiction Medicine,Department of Internal Medicine, Addiction Unit
[3] Yale School of Medicine,undefined
[4] Hospital Universitari Germans Trias i Pujol,undefined
[5] Universitat Autònoma de Barcelona,undefined
来源：
Addiction Science & Clinical Practice | / 19卷
关键词：
Alcohol use disorder; Alcohol-associated liver disease; Treatment; Addiction medicine; Hepatology;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Alcohol-associated liver disease is currently the leading cause of liver transplantation and liver deaths both in Europe and the United States. Efficacious treatments exist for alcohol use disorder, but they are seldomly prescribed for patients who need them. Besides, the presence of liver cirrhosis can complicate pharmacological treatment choices. In this review, we discuss established and innovative treatment strategies to treat unhealthy alcohol use in patients with alcohol-associated liver disease. We also describe the experience of our own institutions, Hospital Universitari Germans Trias i Pujol in Badalona (Spain) and Yale-New Haven Health and Yale Medicine (Connecticut. United States of America).
引用
收藏
相关论文
共 322 条
[1]  
Simonetto DA(2020)Outpatient management of alcohol-related liver disease Lancet Gastroenterol Hepatol 5 485-493
[2]  
Shah VH(2017)Prevalence of 12-month alcohol use, high-risk drinking, and DSM-IV alcohol use disorder in the United States, 2001–2002 to 2012–2013: results from the national epidemiologic survey on alcohol and related conditions JAMA Psychiat 74 911-923
[3]  
Kamath PS(2018)Trends in adult alcohol use and binge drinking in the early 21st-century United States: a meta-analysis of 6 national survey series Alcohol Clin Exp Res 42 1939-1950
[4]  
Grant BF(2018)Mortality due to cirrhosis and liver cancer in the United States, 1999–2016: observational study BMJ. 155 1154-1163.e3
[5]  
Chou SP(2018)Changing trends in etiology-based annual mortality from chronic liver disease, from 2007 through 2016 Gastroenterology 77 516-524
[6]  
Saha TD(2022)The stigma of alcohol-related liver disease and its impact on healthcare J Hepatol 368 365-373
[7]  
Grucza RA(2013)Clinical practice. Alcohol use in adults N Engl J Med. 379 1251-1261
[8]  
Sher KJ(2018)Alcohol use in patients with chronic liver disease N Engl J Med 70 410-417
[9]  
Kerr WC(2019)Diagnosis and treatment of alcohol use disorder in patients with end-stage alcoholic liver disease Hepatology 73 2039-2050
[10]  
Tapper EB(2021)Reducing the global burden of alcohol-associated liver disease: a blueprint for action Hepatology 71 306-333
12345678910